2021 Annual Meeting

Date: October 14-16
Location: Virtual
October 15 & 16 – Scientific & Clinical Abstract Presentations (0900-1500 CDT)
October 16 – Symposium on Epilepsy and Neoplasms (0900-1400 CDT)

Purchase Tickets

Earlybird Pricing Ends Oct 1.

Call for Abstracts 

The deadline to submit has been extended to September 17th.

Scientific and clinical abstracts should be structured, concise, and should convey the essential findings. The abstract may not exceed 250 words. It should state the rationale, objectives, findings, and conclusions of the presentation. Finally, two to three learning objectives are required.

Preliminary Goals & Objectives
Scientific Abstract Presentations

Review of current clinical and basic science research pertaining to neuropathology with a focus on Canadian centres, but overall international participation. Also a platform for Canadian residents and trainees to present their recent work.

Diagnostic Case Presentations

Interactive discussion of rare and challenging neuropathological cases encountered by participants in their recent practice. Electronic slides and imaging results are distributed prior to meeting. Often includes case presentation by residents and illustrates advances in disease classification and diagnostic technique.

Overall learning objectives for the meeting

At the end of the meeting participants will:

  1. Describe recent developments in several areas of neuropathology with particular emphasis on the neuropathology of epilepsy and neoplasms.
  2. Discuss original research and challenging diagnostic cases with colleagues.
  3. Compare the practice of neuropathology on an individual and departmental level across Canadian centres.

Program

Please see the draft schedule below.

 

We will be making updates as they are confirmed.

0850-0900 Opening Remarks Peter Gould, CANP President
Peter Schutz, CANP Secretary-Treasurer
0900-1000 Session 1: Scientific Abstract Presentations 
Moderator: TBD
0900-0915 Abstract 1: TBD
0915-0930 Abstract 2: TBD
0930-0945 Abstract 3: TBD
0945-1000 Abstract 4: TBD
1000-1015 Break
1015-1215 Session 2: Neuropathology Practice  I – New WHO Classification
Moderator: TBD
1015-1105 Invited Lecture:
Topic: New WHO classification with particular emphasis on
infiltrative gliomas, title tba.
Daniel Brat, MD PhD
1105-1125 Invited Lecture:
Title: WHO 2021- Implementation in Canada
Topic: Implications of the new WHO classification for practical

molecular diagnostic work with emphasis on pediatric neoplasms.
Cynthia Hawkins, MD PhD
1125-1140 Invited Lecture:
Topic: Implications of the new WHO classification for practical
molecular diagnostic work with emphasis on pediatric neoplasms,
title tba.
Stephen Yip, MD PhD
1140-1215 Panel Discussion
1215-1330 Break
1330-1500 Session 3: Scientific Abstract Presentations 
Moderator: TBD
1330-1345 Abstract 5: TBD  
1345-1400 Abstract 6:TBD  
1400-1415 Abstract 7: TBD  
1415-1430 Abstract 8:TBD  
1430-1445 Abstract 9:TBD  
1445-1500 Abstract 10:TBD  
0900-1020 Session 1: Diagnostic Case Presentations
Moderator: TBD
0900-0920 Case 1
0920-0940 Case 2
0940-1000 Case 3
1000-1020 Case 4
1020-1115 Break
1115-1215 Session 2: Diagnostic Case Presentations
Moderator: TBD
1115-1135 Case 5
1135-1155 Case 6
1155-1215 Case 7
1215-1330 Break
1330-1415 Session 3: Neuropathology Practice II – Forum
Invited topics for discussion and follow up of neuropathology practice topics from last year.

Moderator: TBD
1415-1515 Session 4: Diagnostic Case Presentations
Moderator: TBD
1415-1435 Case 8
1435-1455 Case 9
1455-1515 Case 10
0900-0910 Welcome & Introductions and Pre-Test
Moderator: Peter Gould
0910-1000 David Robertson Invited Lecture:
Topic: New insights into epilepsy associated neoplasms, title tba.
Moderator: Peter Gould
Eleonora Aronica, MD PhD
1000-1050 Jerzy Olszewsky Invited Lecture:
Topic: SUDEP, title tba
Moderator: Peter Gould
Maria Thom, MD
1050-1110 Break
1110-1200 Gordon Mathieson Invited Lecture:
Title: Why are some cerebral malformations more epileptogenic than others? Clues from developmental neuropathology
Topic: Epileptogenic mechanisms in cortical malformation.

Moderator: TBD
Harvey Sarnat, MD PhD
1200-1250 Invited Lecture:
Topic: Epilepsy as connectivity disease and surgical implications,
title tba.
Moderator: TBD
George Ibrahim, MD PhD
1250-1320 Post-Test; Resident prizes; Concluding remarks
Moderator: Peter Gould, Peter Schutz

Invited Lecturers

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Invited Lecturers

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Mary Tom Award

Best Clinical Paper

Winners will be announced after the annual meeting

Morrison H. Finlayson Award

Best Basic Science

Winners will be announced after the annual meeting

Scientific Abstracts

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Diagnostic Case Studies

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Continuing Professional Development Information

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by theCanadian Association of Neuropathologists. You may claim a maximum of 13.25 hours (credits are automatically calculated) 

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits. Information on the process to convert Royal College MOC credit to AMA credit can be found at www.ama-assn.org/go/internationalcme

In keeping with CMA guidelines, program content and selection of speakers are the responsibility of the program committee. Support is directed towards the costs of the course and not to individual speakers. No commercial support has been solicited for this meeting.